Collectively, our data suggest that, in NSCLC, the increase in RANBP9 together with the decrease in RANBP10 works in concert to determine proteome and ubiquitylome changes that potentially directly and indirectly modulate many other proteins (Supplementary Fig. 7A-P). Here, RANBP10 is linked to non-small cell lung carcinoma.